Glaukos Announces Participation in Upcoming Investor Conferences
Business Wire•03/11/2026•07:00 ET
0
Key Highlights
- ➤Glaukos management to participate in four healthcare investor conferences during November and December 2026
- ➤Events scheduled in New York City, London, and Miami
- ➤Live and archived event webcasts available through Glaukos’s investor website
Expert Statements
Chris Lewis, Vice President, Investor Relations & Corporate Affairs at Glaukos
“Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences:”
Glaukos Announces Participation in Upcoming Investor Conferences
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences:
Get started
Create a free account to read the full story.